French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
In agreement with Afssaps, the company Biomérieux, informed the 02/08/07, the users of the reagent VIDAS Estradiol of the withdrawal of three batches of reagent following a lack of stability. The users of this device concerned by this defect, in France, have received the attached mail (02/08/2007) (26 KB)